Literature DB >> 2341181

The HpmA hemolysin is more common than HlyA among Proteus isolates.

K G Swihart1, R A Welch.   

Abstract

Two different hemolysins, HpmA and HlyA, have been reported in Proteus spp. To study the distribution of these hemolysins among Proteus strains, isolates from various infections and normal feces were screened for hemolysin production. All 63 Proteus mirabilis strains and 23 of the 24 Proteus vulgaris strains produced a calcium-independent hemolytic activity detectable in cell-free supernatants. The calcium-independent activity was due to HpmA; this activity correlated with the presence of hpmA sequences and the production of an extracellular 166-kilodalton (kDa) protein that reacted with anti-HpmA antiserum. HpmA- mutants, constructed by deletion of the central portion of the hpmA gene, did not produce the 166-kDa protein and were no longer hemolytic when compared with their respective parent strains. Among the 87 P. mirabilis and P. vulgaris isolates examined, calcium-dependent hemolytic activity was produced by only two P. vulgaris strains. These strains produced a 110-kDa protein which comigrated with the Escherichia coli hemolysin (HlyA) antibodies in immunoblots. These studies show that Proteus spp. produce two distinct extracellular hemolysins, with nearly all strains producing the calcium-independent hemolysin, HpmA, but only an occasional P. vulgaris isolate producing HlyA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341181      PMCID: PMC258735          DOI: 10.1128/iai.58.6.1853-1860.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB).

Authors:  T S Uphoff; R A Welch
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

2.  Epidemiology of nosocomial infection due to Gram-negative bacilli: aspects relevant to development and use of vaccines.

Authors:  W E Stamm; S M Martin; J V Bennett
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

3.  Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.

Authors:  P G Peerbooms; A M Verweij; P L Oe; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

4.  Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.

Authors:  D Kolodrubetz; T Dailey; J Ebersole; E Kraig
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans.

Authors:  B H Minshew; J Jorgensen; M Swanstrum; G A Grootes-Reuvecamp; S Falkow
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

6.  Vero cell invasiveness of Proteus mirabilis.

Authors:  P G Peerbooms; A M Verweij; D M MacLaren
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Molecular characterization of the hemolysin determinant of Serratia marcescens.

Authors:  K Poole; E Schiebel; V Braun
Journal:  J Bacteriol       Date:  1988-07       Impact factor: 3.490

8.  Alterations of amino acid repeats in the Escherichia coli hemolysin affect cytolytic activity and secretion.

Authors:  T Felmlee; R A Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Investigation of the haemolytic activity of Proteus mirabilis strains.

Authors:  P G Peerbooms; A M Verweij; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1983-04       Impact factor: 2.271

10.  Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.

Authors:  K Kotelko; W Kaca; A Rózalski; M Deka
Journal:  Acta Microbiol Pol       Date:  1983
View more
  18 in total

1.  Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.

Authors:  H L Mobley; G R Chippendale; K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Structural and functional studies of truncated hemolysin A from Proteus mirabilis.

Authors:  Todd M Weaver; Joshua A Smith; Jason M Hocking; Lucas J Bailey; Grayson T Wawrzyn; David R Howard; Laura A Sikkink; Marina Ramirez-Alvarado; James R Thompson
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

Review 3.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 4.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

Review 5.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

6.  Internalization of Proteus mirabilis by human renal epithelial cells.

Authors:  G R Chippendale; J W Warren; A L Trifillis; H L Mobley
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 7.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Cytotoxic activity of the Proteus hemolysin HpmA.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function.

Authors:  M D Island; H L Mobley
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

10.  Multimodal supervision programme to reduce catheter associated urinary tract infections and its analysis to enable focus on labour and cost effective infection control measures in a tertiary care hospital in India.

Authors:  Namita Jaggi; Pushpa Sissodia
Journal:  J Clin Diagn Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.